Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-26 @ 5:13 PM
Study NCT ID:
NCT05794204
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2023-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RMP-A03 Ocular Suspension in Patients With Pterygium
Sponsor:
Suzhou Raymon Pharmaceuticals Company, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-20
First Submit QC Date:
None
Study First Post Date:
2023-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-04-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-12-03
Last Update Post Date:
2024-12-06
Last Update Post Date Type:
ACTUAL